It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Parkinson’s disease (PD) is a neurodegenerative disorder characterized by motor and non-motor symptoms. Dyskinesia and motor fluctuations are complications of PD medications. An objective measure of on/off time with/without dyskinesia has been sought for some time because it would facilitate the titration of medications. The objective of the dataset herein presented is to assess if wearable sensor data can be used to generate accurate estimates of limb-specific symptom severity. Nineteen subjects with PD experiencing motor fluctuations were asked to wear a total of five wearable sensors on both forearms and shanks, as well as on the lower back. Accelerometer data was collected for four days, including two laboratory visits lasting 3 to 4 hours each while the remainder of the time was spent at home and in the community. During the laboratory visits, subjects performed a battery of motor tasks while clinicians rated limb-specific symptom severity. At home, subjects were instructed to use a smartphone app that guided the periodic performance of a set of motor tasks.
Measurement(s) | body movement coordination trait • Movement Disorder Society Unified Parkinson’s Disease Rating Scale Questionnaire • Medication • motor coordination/balance trait • sleep pattern • MDS-UPDRS Tasks and Simulated Activities of Daily Living (in-clinic) • Activity of Daily Living |
Technology Type(s) | Accelerometer • body movement/behavior method • Clinical Observation • smartphone • Subject Diary |
Factor Type(s) | age of patient • gender of patient • timing of medication intake |
Sample Characteristic - Organism | Homo sapiens |
Machine-accessible metadata file describing the reported data:
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 Spaulding Rehabilitation Hospital, Department of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, USA (GRID:grid.416228.b) (ISNI:0000 0004 0451 8771)
2 Spaulding Rehabilitation Hospital, Department of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, USA (GRID:grid.416228.b) (ISNI:0000 0004 0451 8771); Rutgers University, Department of Rehabilitation and Movement Sciences, Newark, USA (GRID:grid.430387.b) (ISNI:0000 0004 1936 8796)
3 Intel Corporation, IT Advanced Analytics, HaMerkaz, Israel (GRID:grid.416228.b)
4 Icahn School of Medicine at Mount Sinai, Department of Neurology, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351)
5 Massachusetts General Hospital, Department of Neurology, Harvard Medical School, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924)
6 Sage Bionetworks, Seattle, USA (GRID:grid.430406.5) (ISNI:0000 0004 6023 5303)
7 Intel Corporation, IT Advanced Analytics, HaMerkaz, Israel (GRID:grid.430406.5)
8 Brigham and Women’s Hospital, Department of Neurology, Harvard Medical School, Boston, USA (GRID:grid.62560.37) (ISNI:0000 0004 0378 8294)
9 Michael J Fox Foundation, New York, USA (GRID:grid.430781.9) (ISNI:0000 0004 5907 0388)
10 Icahn School of Medicine at Mount Sinai, Department of Neurology, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351); Central Queensland University, School of Engineering and Technology, Rockhampton, Australia (GRID:grid.1023.0) (ISNI:0000 0001 2193 0854)
11 Spaulding Rehabilitation Hospital, Department of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, USA (GRID:grid.416228.b) (ISNI:0000 0004 0451 8771); Harvard University, Wyss Institute for Biologically Inspired Engineering, Cambridge, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)